WSO welcomes partnership with Ipsen

08 Jul 2020

WSO and Ipsen have agreed to a new partnership that will focus on addressing life after stroke through provision of high quality education.

WSO is delighted to announce a new partnership with Ipsen pharmaceutical. Ipsen has a long-standing interest in improving the quality of life for stroke survivors, in particular patients experiencing post-stroke spasticity. Stroke is a leading cause or disability globally, accounting for 116 million years of healthy life lost each year. Ipsen's Bronze level support will help othe Organization's programs to raise awareness of the immediate and longer-term needs stroke survivors, as well as to develop and deliver accessible high quality educational content focused on post-stroke care via the World Stroke Academy.

Steven Hildemann, MD, PhD, Chief Medical Officer at Ipsen welcomed the new 'Here at Ipsen, we’re incredibly proud of our new partnership with the World Stroke Organization. Their mission to reduce the global burden of stroke through prevention, treatment and long-term care, is something we support wholeheartedly. Improving the lives of patients after stroke remains an area of high unmet medical need. We are driven to develop and provide access to innovative therapies for people living with debilitating conditions such as post-stroke spasticity. We look forward to working together with the World Stroke Organization to deliver meaningful progress for patients. This partnership confirms our vision and mission to improve patient outcomes through close collaboration with patients, carers and healthcare professionals.'

For more information on becoming a corporate funding partner please visit our website, or contact awiseman@world-stroke.org

Back to the top